MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0003313
Mebita Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.91 Cr
▲ 14% YoY
Net profit · FY 2025
₹24.95 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹67.82 Lakh
EBITDA margin 8.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹11.71 Lakh
Issued & subscribed
Open charges
₹1.26 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
48
Provident fund records
About Mebita Pharmaceutical Private Limited
Data last updated:
Mebita Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC354287. Its GSTIN is 10AAMCM9031A1Z0 (Bihar). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹11.71 Lakh. It is led by directors including Narendra Nath Thakur (Managing Director) and Rupesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 52 Ground Floor West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.91 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹24.95 Lakh (net margin 3.2%) and EBITDA of ₹67.82 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
The company has about 48 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.26 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Mebita Pharmaceutical Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0003313). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mebitapharmaceutical.com.
Company details
CIN U24290DL2019PTC354287
Registration Number 354287
Incorporation Date 27 August 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0003313
Recognitions & Rankings of Mebita Pharmaceutical
Contact details
Mebita Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its website is mebitapharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 52 Ground Floor West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mebita Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Mebita Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mebita Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Mebita Pharmaceutical Private Limited, buy the company report.
Financials of Mebita Pharmaceutical Private Limited
FY 2024 filings availableMebita Pharmaceutical Private Limited reported revenue of ₹7.91 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹7.91 Cr ▲ 14%
Net profit · FY 2025
₹24.95 Lakh margin 3.2%
EBITDA · FY 2025
₹67.82 Lakh margin 8.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 49%
5 years · compounded
▲ 255%
Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 14% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mebita Pharmaceutical Private Limited, buy the company report.
Board of directors of Mebita Pharmaceutical Private Limited
Mebita Pharmaceutical has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupesh Kumar | Director | 27 Aug 2019 | 7 Years 1 Months | Current |
| Nikhil Ranjan | Director | 27 Aug 2019 | 7 Years 1 Months | Current |
| Narendra Nath Thakur | Managing Director | 27 Aug 2019 | 7 Years 1 Months | Current |
| Vanibhushan | Director | 04 May 2022 | 4 Years 5 Months | Current |
| Abhimanyu Kumar | Director | 28 Feb 2020 | 6 Years 7 Months | Current |
Peer comparison
Mebita Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enkay Florals Private Limited | ₹8.13 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Agrosun Zinc Products Private Limited | ₹8.06 Cr (FY 2025) | 31.0% | Doddaballapur, Karnataka, India | |||
| JMS Mediequip Healthcare Private Limited | ₹8.04 Cr (FY 2025) | 14.0% | Jaipur, Rajasthan, India | |||
| Mak Ampoules Pvt Ltd | ₹8.04 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Adelante Lifesciences Private Limited | ₹8.01 Cr (FY 2025) | 447.0% | Solan, Himachal Pradesh, India | |||
| Mebita Pharmaceutical Private Limitedthis company | ₹7.91 Cr (FY 2025) | ₹24.95 Lakh | 3.2% | 14.0% | 48 | Delhi, India |
| Hindocare (India) Private Limited | ₹7.9 Cr (FY 2025) | 85.0% | Kapu, Karnataka, India | |||
| Indospectrum Pharmaceuticals Private Limited | ₹7.88 Cr (FY 2025) | 13.0% | Mysore, Karnataka, India | |||
| Tantra-Chem India Private Limited | ₹7.88 Cr (FY 2025) | 45.0% | Lote, Maharashtra, India | |||
| Trans Lifescience Medcare Private Limited | ₹7.8 Cr (FY 2024) | 29.0% | Sonipat, Haryana, India | |||
| Indionix Medical Device Private Limited | ₹7.79 Cr (FY 2025) | 345.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Mebita Pharmaceutical Private Limited, buy the company report.
Auditor
Mebita Pharmaceutical Private Limited is audited by MANISH B GUPTA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH B GUPTA & CO | FY 2022 | 025782N |
Shareholding
The shareholding of Mebita Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mebita Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2023 | 100821330 | Hdfc Bank Limited | ₹6.81 Lakh | Open | |
| 29 Jul 2022 | 100627973 | Hdfc Bank Limited | ₹95 Lakh | Open | |
| 21 Oct 2021 | 100493878 | Others | ₹24 Lakh | Open |
To see the full charge records of Mebita Pharmaceutical Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Mebita Pharmaceutical Private Limited has 1 court case on record: 1 filed by Mebita Pharmaceutical. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
To see the full case history of Mebita Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mebita Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mebita Pharmaceutical Private Limited has a workforce of 48 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
48
Active EPFO establishments
1
Employee growth
9.09%
GST
Mebita Pharmaceutical has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAMCM9031A1Z0 | Bihar | Active | 12 Jan 2020 |
| 20AAMCM9031A1ZZ | Jharkhand | Active | 28 Nov 2021 |
To see the full GST registrations and return filing status of Mebita Pharmaceutical Private Limited, buy the company report.
Recent activity
Mebita Pharmaceutical Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Vanibhushan ceased to be Additional Director on 28 Sep 2023.
AGM
Mebita Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Mebita Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited of Rs. 95.00 Lakh registered on 29 Jul 2022 with Charge ID 100627973 was modified on 13 Feb 2024.
Ceased
Vanibhushan ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.81 Lakh with Charge ID 100821330 was registered on 31 May 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 95.00 Lakh with Charge ID 100627973 was registered on 29 Jul 2022.
Appointed
Vanibhushan was appointed as Director.
Charges
A charge with Others amounted to Rs. 24.00 Lakh with Charge ID 100493878 was registered on 21 Oct 2021.
Ceased
Abhimanyu Kumar ceased to be Additional Director.
Appointed
Abhimanyu Kumar was appointed as Director.
Ceased
Narendra Nath Thakur ceased to be Director.
Appointed
Narendra Nath Thakur was appointed as Managing Director.
3 earlier events are in the company report.
Frequently asked questions
Mebita Pharmaceutical is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 August 2019 (7+ years old) and is registered under CIN U24290DL2019PTC354287.
Mebita Pharmaceutical has 5 current directors:
- Narendra Nath Thakur - Managing Director
- Rupesh Kumar - Director
- Nikhil Ranjan - Director
- Vanibhushan - Director
- Abhimanyu Kumar - Director
The latest financial statements of Mebita Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mebita Pharmaceutical is 10AAMCM9031A1Z0, registered in Bihar. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 20AAMCM9031A1ZZ (Jharkhand).
The CIN (Corporate Identification Number) of Mebita Pharmaceutical is U24290DL2019PTC354287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mebita Pharmaceutical has 1 court case on record: 1 filed by the company. 1 is pending.
Mebita Pharmaceutical was incorporated on 27 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mebita Pharmaceutical by revenue are Enkay Florals Private Limited, Agrosun Zinc Products Private Limited, JMS Mediequip Healthcare Private Limited, Mak Ampoules Pvt Ltd, Adelante Lifesciences Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Vanibhushan ceased to be Additional Director on 28 Sep 2023. Vanibhushan was appointed as Director on 04 May 2022. Abhimanyu Kumar ceased to be Additional Director on 31 Dec 2020. Mebita Pharmaceutical has 8 board changes on record in total.
Yes, Mebita Pharmaceutical is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0003313).
Mebita Pharmaceutical can be reached through the website mebitapharmaceutical.com. Its registered office is in Delhi, India.